Literature DB >> 25014786

The role of mechanical forces in tumor growth and therapy.

Rakesh K Jain1, John D Martin, Triantafyllos Stylianopoulos.   

Abstract

Tumors generate physical forces during growth and progression. These physical forces are able to compress blood and lymphatic vessels, reducing perfusion rates and creating hypoxia. When exerted directly on cancer cells, they can increase cells' invasive and metastatic potential. Tumor vessels-while nourishing the tumor-are usually leaky and tortuous, which further decreases perfusion. Hypoperfusion and hypoxia contribute to immune evasion, promote malignant progression and metastasis, and reduce the efficacy of a number of therapies, including radiation. In parallel, vessel leakiness together with vessel compression causes a uniformly elevated interstitial fluid pressure that hinders delivery of blood-borne therapeutic agents, lowering the efficacy of chemo- and nanotherapies. In addition, shear stresses exerted by flowing blood and interstitial fluid modulate the behavior of cancer and a variety of host cells. Taming these physical forces can improve therapeutic outcomes in many cancers.

Entities:  

Keywords:  solid stress; stress alleviation; tumor microenvironment; tumor perfusion; vascular hyperpermeability; vascular normalization; vessel compression

Mesh:

Substances:

Year:  2014        PMID: 25014786      PMCID: PMC4109025          DOI: 10.1146/annurev-bioeng-071813-105259

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  142 in total

Review 1.  Cellular fluid mechanics and mechanotransduction.

Authors:  John M Tarbell; Sheldon Weinbaum; Roger D Kamm
Journal:  Ann Biomed Eng       Date:  2005-12       Impact factor: 3.934

2.  Mechanically activated integrin switch controls alpha5beta1 function.

Authors:  Julie C Friedland; Mark H Lee; David Boettiger
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

3.  Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination.

Authors:  Daniel Keizman; Peng Huang; Mario A Eisenberger; Roberto Pili; Jenny J Kim; Emmanuel S Antonarakis; Hans Hammers; Michael A Carducci
Journal:  Eur J Cancer       Date:  2011-05-18       Impact factor: 9.162

4.  Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.

Authors:  A Gregory Sorensen; Kyrre E Emblem; Pavlina Polaskova; Dominique Jennings; Heisoog Kim; Marek Ancukiewicz; Meiyun Wang; Patrick Y Wen; Percy Ivy; Tracy T Batchelor; Rakesh K Jain
Journal:  Cancer Res       Date:  2011-11-29       Impact factor: 12.701

5.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation.

Authors:  A J Leu; D A Berk; A Lymboussaki; K Alitalo; R K Jain
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

6.  Lymphatic metastasis in the absence of functional intratumor lymphatics.

Authors:  Timothy P Padera; Ananth Kadambi; Emmanuelle di Tomaso; Carla Mouta Carreira; Edward B Brown; Yves Boucher; Noah C Choi; Douglas Mathisen; John Wain; Eugene J Mark; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2002-04-25       Impact factor: 47.728

7.  Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor.

Authors:  M Welter; K Bartha; H Rieger
Journal:  J Theor Biol       Date:  2007-09-26       Impact factor: 2.691

8.  Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.

Authors:  Jeroen Hagendoorn; Ricky Tong; Dai Fukumura; Qingcong Lin; Jennifer Lobo; Timothy P Padera; Lei Xu; Raju Kucherlapati; Rakesh K Jain
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

10.  Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model.

Authors:  Triantafyllos Stylianopoulos; Konstantinos Soteriou; Dai Fukumura; Rakesh K Jain
Journal:  Ann Biomed Eng       Date:  2012-08-02       Impact factor: 3.934

View more
  264 in total

1.  Quantification of Microvascular Tortuosity during Tumor Evolution Using Acoustic Angiography.

Authors:  Sarah E Shelton; Yueh Z Lee; Mike Lee; Emmanuel Cherin; F Stuart Foster; Stephen R Aylward; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-04-07       Impact factor: 2.998

Review 2.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

3.  Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.

Authors:  Hongchi Yu; Yang Shen; Jingsi Jin; Yingying Zhang; Tang Feng; Xiaoheng Liu
Journal:  Cell Adh Migr       Date:  2017-06-22       Impact factor: 3.405

Review 4.  Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors.

Authors:  Ning Zhu; Shanshan Weng; Juan Wang; Jiaqi Chen; Linzhen Yu; Xuefeng Fang; Ying Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

5.  Biomechanical forces in tissue engineered tumor models.

Authors:  Letitia K Chim; Antonios G Mikos
Journal:  Curr Opin Biomed Eng       Date:  2018-03-26

6.  Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy.

Authors:  Gabriel Ramirez; Ashley R Proctor; Ki Won Jung; Tong Tong Wu; Songfeng Han; Russell R Adams; Jingxuan Ren; Daniel K Byun; Kelley S Madden; Edward B Brown; Thomas H Foster; Parisa Farzam; Turgut Durduran; Regine Choe
Journal:  Biomed Opt Express       Date:  2016-08-24       Impact factor: 3.732

7.  Nonlinear studies of tumor morphological stability using a two-fluid flow model.

Authors:  Kara Pham; Emma Turian; Kai Liu; Shuwang Li; John Lowengrub
Journal:  J Math Biol       Date:  2018-03-15       Impact factor: 2.259

Review 8.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

Review 9.  Physical traits of cancer.

Authors:  Hadi T Nia; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2020-10-30       Impact factor: 47.728

10.  Biomechanical modelling of spinal tumour anisotropic growth.

Authors:  Ioanna Katsamba; Pavlos Evangelidis; Chrysovalantis Voutouri; Alkiviadis Tsamis; Vasileios Vavourakis; Triantafyllos Stylianopoulos
Journal:  Proc Math Phys Eng Sci       Date:  2020-06-03       Impact factor: 2.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.